Relapse of immune thrombocytopenia after COVID-19 vaccination.

van Dijk, Wobke E M; Schutgens, Roger E G

van Dijk, Wobke E M; Schutgens, Roger E G.

van Dijk WEM; Center for Benign Hematology, Thrombosis and Hemostasis, Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands.
Schutgens REG; Center for Benign Hematology, Thrombosis and Hemostasis, Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands.

Eur J Haematol ; 108(1): 84-85, 2022 01.

Article in English | MEDLINE | ID: covidwho-1443257

Subject(s)

COVID-19 Vaccines/adverse effects; Purpura, Thrombocytopenic, Idiopathic/etiology; Adult; Aged; COVID-19 Vaccines/immunology; Cohort Studies; Female; Hemorrhage/blood; Hemorrhage/etiology; Hemorrhage/immunology; Humans; Male; Middle Aged; Netherlands; Platelet Count; Purpura, Thrombocytopenic, Idiopathic/blood; Purpura, Thrombocytopenic, Idiopathic/immunology; Recurrence; Retrospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Purpura, Thrombocytopenic, Idiopathic / COVID-19 Vaccines Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Eur J Haematol Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: Ejh.13713

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google